- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0007390

About Adept Pharma and Bioscience Excellence Private Limited
Data last updated:
Adept Pharma and Bioscience Excellence Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 13 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2012PTC081436. Its GSTIN is 36AALCA1904F2ZY (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.98 Cr. It is led by directors including Arikatla Govardhana Reddy (Managing Director) and Arikatla Jyothiraditya Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 30 & 31 Survey No. 196 197 & 198 Rajiv Gandhi Nagar Moosapet Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2026, the company reported a revenue of ₹7.99 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹93.38 Lakh (net margin 11.7%) and EBITDA of ₹3.13 Cr (EBITDA margin 39.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 18% over five years.
The company is associated with 1 brand: Adept Pharma and Bioscience Excellence. As per MCA filings, the company has open charges of ₹4.26 Cr and satisfied charges of ₹1 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 2 cases are pending. The company has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.45 Cr; the latest was in March 2022.
Adept Pharma and Bioscience Excellence Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0007390). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adeptpharmabio.com.
Company details
CIN history
Adept Pharma and Bioscience Excellence has one previous CIN (Corporate Identification Number): U24239AP2012PTC081436. The current CIN is U24239TG2012PTC081436, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2012PTC081436 | Current |
| U24239AP2012PTC081436 | Previous |
Recognitions & Rankings of Adept Pharma and Bioscience Excellence
Contact details
Adept Pharma and Bioscience Excellence Private Limited's registered office is in Hyderabad, Telangana. Its website is adeptpharmabio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 30 & 31 Survey No. 196 197 & 198 Rajiv Gandhi Nagar Moosapet Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Adept Pharma and Bioscience Excellence operates one associated brand: Adept Pharma and Bioscience Excellence. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers chemical, instrumental, and microbiological testing for pharmaceutical sectors. | adeptpharmabio.com |
Business activity
The main business activity of Adept Pharma and Bioscience Excellence is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
Financials of Adept Pharma and Bioscience Excellence Private Limited
FY 2026 filings availableAdept Pharma and Bioscience Excellence Private Limited reported revenue of ₹7.99 Cr (up 18% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 18% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹7.99 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹93.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 39.2% | ||||
| Net Profit Margin | 11.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
Board of directors of Adept Pharma and Bioscience Excellence Private Limited
Adept Pharma and Bioscience Excellence has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arikatla Govardhana Reddy | Managing Director | 30 Sep 2021 | 5 Years 1 Months | Current |
| Arikatla Jyothiraditya Reddy | Director | 28 Oct 2018 | 8 Years 0 Months | Current |
| Pasam Narasimha Reddy | Director | 06 Jan 2022 | 4 Years 10 Months | Current |
Auditor
Adept Pharma and Bioscience Excellence Private Limited is audited by K. RAMBABU & CO for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K. RAMBABU & CO | FY 2026 | 224953 |
Shareholding
The shareholding of Adept Pharma and Bioscience Excellence Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Feb 2025 | 101080062 | Others | ₹64.3 Lakh | Open | |
| 30 Sep 2024 | 101001208 | Others | ₹85 Lakh | Open | |
| 06 Apr 2023 | 100715676 | Hdfc Bank Limited | ₹21.27 Lakh | Open | |
| 09 Jul 2021 | 100466077 | Hdfc Bank Limited | ₹2.55 Cr | Open | |
| 30 Nov 2021 | 100515001 | Others | ₹55.7 Lakh | Satisfied |
To see the full charge records of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Adept Pharma and Bioscience Excellence Private Limited has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.45 Cr; the latest was in March 2022.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2018 | Funding round | ₹2.45 Cr | Investors: 4 individuals |
To see the full deal history of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Adept Pharma and Bioscience Excellence Private Limited has 8 court cases on record: 4 filed by Adept Pharma and Bioscience Excellence, 4 filed against it. 2 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
| High courts | 4 | 0 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (STC-NI) | Filed against the company by an individual | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Andhra Bank and 1 other | Pending |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed against the company | Disposed |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed against the company | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Andhra Bank, A Government of India Undertaking and 2 Others and 2 others | Disposed |
To see the full case history of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adept Pharma and Bioscience Excellence Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adept Pharma and Bioscience Excellence has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AALCA1904F2ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.
Recent activity
Adept Pharma and Bioscience Excellence Private Limited has 12 board changes on record since 2018: 3 appointments and 9 cessations. The latest: Pasam Narasimha Reddy was appointed as Director on 06 Jan 2022.
13 earlier events are in the company report.
Frequently asked questions
Adept Pharma and Bioscience Excellence is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 13 June 2012 (14+ years old) and is registered under CIN U24239TG2012PTC081436.
Adept Pharma and Bioscience Excellence has 3 current directors:
- Arikatla Govardhana Reddy - Managing Director
- Arikatla Jyothiraditya Reddy - Director
- Pasam Narasimha Reddy - Director
The latest financial statements of Adept Pharma and Bioscience Excellence on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Adept Pharma and Bioscience Excellence is 36AALCA1904F2ZY, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Adept Pharma and Bioscience Excellence is U24239TG2012PTC081436. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adept Pharma and Bioscience Excellence has 8 court cases on record: 4 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Adept Pharma and Bioscience Excellence was incorporated on 13 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Adept Pharma and Bioscience Excellence has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.45 Cr; the latest was in March 2022.
Pasam Narasimha Reddy was appointed as Director on 06 Jan 2022. Arikatla Govardhana Reddy was appointed as Managing Director on 30 Sep 2021. Arikatla Govardhana Reddy ceased to be Managing Director on 20 Sep 2021. Adept Pharma and Bioscience Excellence has 12 board changes on record in total.
Yes, Adept Pharma and Bioscience Excellence is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0007390).

